The Use of Nanobiotechnology in Immunology and Vaccination

Nanotechnology uses the unique properties of nanostructures with a size of 1 to 200 nanometers. Different nanoparticles have shown great promise for the production of new vaccines and drugs. Nanostructures can be used to deliver immunological compounds more effectively than microstructures to target...

Full description

Saved in:
Bibliographic Details
Published in:Vaccines (Basel) 2021-01, Vol.9 (2), p.74
Main Authors: Keikha, Reza, Daliri, Karim, Jebali, Ali
Format: Article
Language:English
Subjects:
Adjuvants
Antibodies
Antigens
Cholesterol
Communication
Coronaviruses
Drugs
Genetic engineering
Hepatitis
Hydrogels
Immune system
Immunology
Immunosuppressive agents
Infectious diseases
Influenza
Ligands
Lymphatic system
Lymphocytes
Medical research
Melanoma
Nanoparticles
Nanostructure
nanostructures
Nanotechnology
Peptides
Proteins
Tumor necrosis factor-TNF
vaccination
Vaccines
Viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nanotechnology uses the unique properties of nanostructures with a size of 1 to 200 nanometers. Different nanoparticles have shown great promise for the production of new vaccines and drugs. Nanostructures can be used to deliver immunological compounds more effectively than microstructures to target sites. Different nanostructures can be applied to form a new generation of vaccines, adjuvants, and immune system drugs. The goal of nanotechnology is to better respond to a wide range of infectious and non-infectious diseases.
ISSN:2076-393X
2076-393X
DOI:10.3390/vaccines9020074